CTRI/2018/08/015291进行中（未招募）未知
Outcomes of gemcitabine-docetaxel combination in patients of recurrent or metastatic soft tissue sarcoma: a retrospective analysis
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- A
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1) Age 18-60 years
- •2) Histologically/Cytologically proven metastatic/advanced(recurrent) STS
- •3) Previously treated with at least one first-line regimen in neo-adjuvant or advanced or metastatic setting and either progressed on chemotherapy or recurred to an advanced stage, after failure of/intolerance to first line systemic chemotherapy
- •4)Received at least 3 cycles of Gemcitabine-Docetaxel combination as second line therapy in the advanced(recurrent) or metastatic settling
排除标准
- •Incomplete data on EMR or case records
研究者
相似试验
已完成
2 期
Clinical study of gemcitabine plus docetaxel in patient with refractory bone and soft tissue sarcomasbone and soft tissue sarcomaJPRN-UMIN000017967Juntendo University Urayasu Hospital10
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Biological Targeted TreatmentSUCCESS B-Trial - SUCCESS-BPatientinnen mit primärem epithelialem invasivem MammakarzinomEUCTR2007-001094-29-DEKlinikum der LM
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Extended Bisphosphonate and Surveillance-Trial SUCCESS-Trial - SUCCESSThis is an open-label, multicenter, 2x2 factorial design, randomized controlled, Phase III study comparing the time to recurrence after randomisation in patients with early primary breast cancer.EUCTR2005-000490-21-DE1. Frauenklinik der LMU- Innenstadt
招募中
2 期
Study of gemcitabine docetaxel in synovial sarcoma in relapsed metastatic settingCTRI/2020/02/023612Department of Medical Oncology
进行中（未招募）
1 期
A fase I/II trial with docetaxel and gemcitabine in hormone refractory prostate cancerHormone fractory prostate cancerEUCTR2004-002353-31-DKOrganisation name was not entered60